Ibn Sina Hospital Report issue

Academic/Hospital
Founded: Baghdad Iraq (1965)

Organization Overview

First Clinical Trial
2014
NCT02021864
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Dr. Sima Hashemipour | Ibn Sina Hospital | Muhammad Fawzy

Active Ingredients

Drugs in Other Trials (5)

cytochalasin b (1 trial)

latrunculin b (1 trial)

multivitamins (1 trial)

strontium-89 (1 trial)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 4
  • # of Trial APIs: 5